2023
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.
Future oncology (London, England)
PubMed • Publisher's siteResearch at a glance
Top areas of exploration
- Neoplasm Recurrence, Local , 25 publications
- Combined Modality Therapy , 25 publications
- Radiotherapy, Adjuvant , 21 publications
- Radiotherapy Dosage , 21 publications
Research activity
My publications
Filter publications
115 publications
2023
Answering the Call for Radiation Oncologists to Direct Radiopharmaceutical Therapy: Forget the Professional Fee and Get the Hospital to Pay for Support Staff, Infrastructure, and Supplies.
Practical radiation oncology
PubMed • Publisher's site2022
Measuring Radiation Toxicity Using Circulating Cell-Free DNA in Prostate Cancer Patients.
International journal of particle therapy
PubMed • Publisher's site2021
Reirradiation in Conservative Salvage of Recurrent Soft-tissue Sarcoma: An Analysis of Treatment Efficacy and Toxicities.
American journal of clinical oncology
PubMed • Publisher's site2020
Circulating Cell-Free DNA Correlates with Body Integral Dose and Radiation Modality in Prostate Cancer.
International journal of particle therapy
PubMed • Publisher's site